The effect of iron and yttrium additions on glass forming ability and corrosion resistance of Al88Y8-xFe4+x (x = 0, 1, 2 at.%) alloys in the form of ingots and melt-spun ribbons was investigated. The crystalline multiphase structure of ingots and amorphous-crystalline structure of ribbons were examined by a number of analytical techniques including X-ray diffraction, Mössbauer spectroscopy, and transmission electron microscopy. It was confirmed that the higher Fe additions contributed to formation of amorphous structures. The impact of chemical composition and structure of alloys on their corrosion resistance was characterized by electrochemical tests in 3.5% NaCl solution at 25 °C. The identification of the mechanism of chemical reactions taking place during polarization test along with the morphology and internal structure of the surface oxide films generated was performed. It was revealed that the best corrosion resistance was achieved for the Al88Y7Fe5 alloy in the form of ribbon, which exhibited the lowest corrosion current density (jcorr = 0.09 μA/cm2) and the highest polarization resistance (Rp = 96.7 kΩ∙cm2).

The influence of the chemical composition on the crystallization process, amorphous phase formation, and the anticorrosion properties of Al-Zr-Ni-Fe-Y alloys are presented. To reduce the number of experiments, a thermodynamic approach was applied in which the entropy and Gibbs free energy of representative alloys were optimized. The low glass-forming ability of Al-Zr-Ni-Fe-Y alloy systems was related to the crystallization of the Al3Zr phase from the melt. The structural analysis showed that phases containing Ni and Fe, such as Al19Ni5Y3, Al10Fe2Y, and Al23Ni6Y4, played a key role in the formation of amorphous alloys. According to this, the simultaneous addition of Ni/Fe and Y is important to prevent the crystallization of Al-based alloys in the melt. The formation of an amorphous phase in Al80Zr5Ni5Fe5Y5 alloys and the complete amorphization of Al85Ni5Fe5Y5 alloys were responsible for the high corrosion resistance compared with fully crystalline alloys. Moreover, the addition of Y had a significant impact on the anticorrosion properties. The XPS results showed that the alloys tended to form a passive Al2O3 and Y2O3 layer on the surface.

The aim of this work was to characterize the structure and corrosion properties of the MgCa4.5(Gd0.5) alloys surface treated by the micro-arc oxidation (MAO) process. The MgCa4.5 and MgCa4.5Gd0.5 alloy samples were processed by MAO in an electrolyte composed of NaOH (10 g/dm3), NaF (10 g/dm3), NaH2PO4 (5 g/dm3), Na2SiO2·5H2O (10 g/dm3) and water. Two different voltages (120 V and 140 V) were used in the MAO process. The alloys protected by an oxide layer formed in the MAO were then the subject of corrosion resistance tests in an environment simulating the human body (Ringer’s solution). After the experiments, the resulting samples were investigated with using SEM, XPS and EDS techniques. The addition of Gd affected the fragmentation of the coating structure, thereby increasing the specific surface; higher voltages during the MAO process increased the number and size of surface pores. Corrosion tests showed that the MgCa4.5Gd0.5 alloys were characterized by low polarization resistances and high corrosion current densities. The studies indicated the disadvantageous influence of gadolinium on the corrosion resistance of MgCa4.5 alloys. The immersion tests confirmed lower corrosion resistance of MgCa4.5Gd0.5 alloys compared to the referenced MgCa4.5 ones. The MgCa4.5 alloy with the MAO coating established at voltage 140 V demonstrated the best anticorrosion properties.

Amorphous and crystalline magnesium alloys, developed for medical applications – especially implantology – present the characteristics of biocompatible magnesium alloys (Mg-Zn, Mg-Zn-Ca, Mg-Ca etc.). This chapter provides a brief description of the role of magnesium in the human body and the use of Mg in medicine. It presents the concept of using magnesium alloys in medicine (advantages and limitations) and the scope of their potential applications (orthopedic implantology, cardiac surgery etc.). The chapter shows classification of magnesium alloys as potential biomaterials, due to their structure (amorphous, crystalline) and alloying elements (rare earth elements, noble metals etc.). The mechanism and in vitro degradation behavior of magnesium alloys with amorphous and crystalline structures are described. The chapter also discusses the influence of alloying elements (rare earth elements, noble metals) on the in vitro degradation process. It also presents the methods of reducing the degradation rate of magnesium alloys by modifying their surface (application of protective layers).

No abstract